{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:30:48Z","timestamp":1788474648296,"version":"build-2803163510"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.prp.2023.154363","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T21:37:08Z","timestamp":1675805828000},"page":"154363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance\u2013 An emphasis on the interaction of signaling pathways"],"prefix":"10.1016","volume":"243","author":[{"given":"Ahmed S.","family":"Doghish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Abulsoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen Saeid","family":"Elshaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhan M.","family":"Abdelmaksoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Bakr","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham A.","family":"El-Mahdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsayed G.E.","family":"Elsakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib1","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.prp.2023.154363_bib2","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ajh.26367","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"25","key":"10.1016\/j.prp.2023.154363_bib3","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib4","article-title":"Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002","volume":"19","author":"Yamamoto","year":"2008","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.prp.2023.154363_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41375-020-01057-5","article-title":"Ethnic and geographic diversity of chronic lymphocytic leukaemia","volume":"35","author":"Yang","year":"2021","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.prp.2023.154363_bib6","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.prp.2023.154363_bib7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.prp.2023.154363_bib8","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ajh.25595","article-title":"Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment","volume":"94","author":"Hallek","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"23","key":"10.1016\/j.prp.2023.154363_bib9","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2009-07-192740","article-title":"Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes","volume":"114","author":"Calin","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.prp.2023.154363_bib10","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ajh.26367","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib11","first-page":"190","article-title":"Guidelines for diagnosis and treatment of chronic lymphocytic leukemia. Krohem B-Cll 2017","volume":"57","author":"Jak\u0161i\u0107","year":"2018","journal-title":"Acta Clin. Croat."},{"key":"10.1016\/j.prp.2023.154363_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154077","article-title":"miR-574, miR-499, miR-125b, miR-106a, and miR-9 potentially target TGFBR-1 and TGFBR-2 genes involving in inflammatory response pathway: Potential novel biomarkers for chronic lymphocytic leukemia","volume":"238","author":"Hadi","year":"2022","journal-title":"Pathol. - Res. Pract."},{"issue":"10a","key":"10.1016\/j.prp.2023.154363_bib13","doi-asserted-by":"crossref","DOI":"10.1101\/gr.2722704","article-title":"Identification of mammalian microRNA host genes and transcription units","volume":"14","author":"Rodriguez","year":"2004","journal-title":"Genome Res"},{"key":"10.1016\/j.prp.2023.154363_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121321","article-title":"miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers","volume":"314","author":"Doghish","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.106978","article-title":"miRNAs as cornerstones in diabetic microvascular complications","volume":"138","author":"Ismail","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.prp.2023.154363_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113977","article-title":"Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions","volume":"157","author":"Abulsoud","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.prp.2023.154363_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271271","article-title":"Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt","volume":"17","author":"Ismail","year":"2022","journal-title":"Plos One"},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249346","article-title":"Clinical characteristics of Egyptian male patients with COVID\u201019 acute respiratory distress syndrome","volume":"16","author":"Doghish","year":"2021","journal-title":"Plos One"},{"key":"10.1016\/j.prp.2023.154363_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154316","article-title":"miRNAs role in bladder cancer pathogenesis and targeted therapy: signaling pathways interplay-a review","author":"El-Mahdy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154363_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153886","article-title":"miRNAs inspirations in hepatocellular carcinoma: detrimental and favorable aspects of key performers","author":"El-Mahdy","year":"2022","journal-title":"Pathol. Res. Pract."},{"issue":"20","key":"10.1016\/j.prp.2023.154363_bib21","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1182\/bloodadvances.2021005726","article-title":"MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells","volume":"6","author":"Matis","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.prp.2023.154363_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2022.133003","article-title":"Target-induced multiple palindrome-mediated strand displacement amplification of Scarecrow-shaped DNA nanoprobe for ultrasensitive detection of MicroRNA","volume":"376","author":"Huang","year":"2023","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.prp.2023.154363_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.106382","article-title":"Defining disease-related modules based on weighted miRNA synergistic network","volume":"152","author":"Li","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"2","key":"10.1016\/j.prp.2023.154363_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2022.12581","article-title":"Inside the chronic lymphocytic leukemia cell: miRNA and chromosomal aberrations","volume":"25","author":"Grenda","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.prp.2023.154363_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.trecan.2016.02.005","article-title":"Novel mechanisms of regulation of miRNAs in CLL","volume":"2","author":"Balatti","year":"2016","journal-title":"Trends Cancer"},{"key":"10.1016\/j.prp.2023.154363_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154183","article-title":"Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway (s) and clinical outcome (s) association","author":"El-Sheikh","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154363_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2022.09.209","article-title":"Interactome battling of lncRNA CCDC144NL-AS1: Its role in the emergence and ferocity of cancer and beyond","author":"Abd El Fattah","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154363_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120923","article-title":"Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: a review","author":"Elsakka","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154363_bib29","doi-asserted-by":"crossref","unstructured":"M. Bakr Zaki A.I. Abulsoud A.M. Elsisi A.S. Doghish O.A.E. Mansour A.I. Amin M.A. Elrebehy M.Y. Mohamed M.A. Goda Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients Diabetes Metab. Syndr. Obes. Targets Ther. 2019 601 611.","DOI":"10.2147\/DMSO.S187422"},{"issue":"7","key":"10.1016\/j.prp.2023.154363_bib30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcjd.2020.12.005","article-title":"Circulating miR-148a-5p and miR-21-5p as novel diagnostic biomarkers in Adult Egyptian male patients with metabolic syndrome","volume":"45","author":"Doghish","year":"2021","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.prp.2023.154363_bib31","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ijbiomac.2022.10.241","article-title":"Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review","volume":"224","author":"Ismail","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154363_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mgene.2018.11.006","article-title":"Diagnostic Significance of miR-639 and miR-10b in \u0392reast Cancer Patients","volume":"19","author":"Ismail","year":"2019","journal-title":"Meta Gene"},{"key":"10.1016\/j.prp.2023.154363_bib33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijbiomac.2022.06.134","article-title":"miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: a spotlight on signaling pathways interplay\u2014A review","volume":"214","author":"Elrebehy","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154363_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154222","article-title":"The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance \u2013 A focus on signaling pathways interplay","volume":"240","author":"Ismail","year":"2022","journal-title":"Pathol. - Res. Pract."},{"issue":"9","key":"10.1016\/j.prp.2023.154363_bib35","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nbt.3947","article-title":"An integrated expression atlas of miRNAs and their promoters in human and mouse","volume":"35","author":"De Rie","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.prp.2023.154363_bib36","doi-asserted-by":"crossref","DOI":"10.1101\/gad.1919710","article-title":"Emerging paradigms of regulated microRNA processing","volume":"24","author":"Newman","year":"2010","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.prp.2023.154363_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/sj.emboj.7601512","article-title":"Processing of intronic microRNAs","volume":"26","author":"Kim","year":"2007","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.prp.2023.154363_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2004.03.065","article-title":"Molecular evolution of a microRNA cluster","volume":"339","author":"Tanzer","year":"2004","journal-title":"J. Mol. Biol."},{"issue":"28","key":"10.1016\/j.prp.2023.154363_bib39","doi-asserted-by":"crossref","first-page":"36984","DOI":"10.1007\/s11356-021-14550-w","article-title":"MicroRNAs' role in the environment-related non-communicable diseases and link to multidrug resistance, regulation, or alteration","volume":"28","author":"Mahmoud","year":"2021","journal-title":"Environ. Sci. Pollut. Res Int"},{"key":"10.1016\/j.prp.2023.154363_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2022.08.002","article-title":"Mitochondrial miRNAs (MitomiRs): Their Potential Roles in Breast and Other Cancers","author":"Erturk","year":"2022","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib41","article-title":"Light-stabilized FHA2 suppresses miRNA biogenesis through interactions with DCL1 and HYL1","volume":"14","author":"Park","year":"2021","journal-title":"J. Mol. Plant"},{"issue":"7014","key":"10.1016\/j.prp.2023.154363_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the Microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.prp.2023.154363_bib43","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1101\/gad.1262504","article-title":"The Drosha-DGCR8 complex in primary microRNA processing","volume":"18","author":"Han","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2023.154363_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123189","article-title":"The role of miRNAs in insulin resistance and diabetic macrovascular complications \u2013 A review","volume":"230","author":"Abdel Mageed","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154363_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121382","article-title":"miRNAs as cornerstones in adipogenesis and obesity","volume":"315","author":"Elkhawaga","year":"2023","journal-title":"Life Sci."},{"issue":"5957","key":"10.1016\/j.prp.2023.154363_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/science.1178705","article-title":"A high-resolution structure of the pre-microRNA nuclear export machinery","volume":"326","author":"Okada","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2004.06.017","article-title":"Single processing center models for human Dicer and bacterial RNase III","volume":"118","author":"Zhang","year":"2004","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.prp.2023.154363_bib48","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.molcel.2022.10.010","article-title":"Structural and functional basis of mammalian microRNA biogenesis by Dicer","volume":"82","author":"Zapletal","year":"2022","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.prp.2023.154363_bib49","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41477-021-01000-1","article-title":"Structural basis of microRNA processing by Dicer-like 1","volume":"7","author":"Wei","year":"2021","journal-title":"Nat. Plants"},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib50","doi-asserted-by":"crossref","first-page":"11538","DOI":"10.1038\/ncomms11538","article-title":"Argonaute-associated short introns are a novel class of gene regulators","volume":"7","author":"Hansen","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2023.154363_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.05.001","article-title":"An overview of microRNAs","volume":"87","author":"Hammond","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.prp.2023.154363_bib52","first-page":"1","article-title":"Regulation of microRNAs, miRNomics","author":"Ergin","year":"2022","journal-title":"Springer"},{"issue":"7149","key":"10.1016\/j.prp.2023.154363_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.prp.2023.154363_bib54","doi-asserted-by":"crossref","DOI":"10.1101\/gad.1705308","article-title":"Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs","volume":"22","author":"Babiarz","year":"2008","journal-title":"Genes Dev."},{"issue":"7","key":"10.1016\/j.prp.2023.154363_bib55","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.cell.2013.11.027","article-title":"Mammalian 5\u2032-capped microRNA precursors that generate a single microRNA","volume":"155","author":"Xie","year":"2013","journal-title":"Cell"},{"issue":"34","key":"10.1016\/j.prp.2023.154363_bib56","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1006432107","article-title":"Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7298","key":"10.1016\/j.prp.2023.154363_bib57","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nature09092","article-title":"A dicer-independent miRNA biogenesis pathway that requires Ago catalysis","volume":"465","author":"Cheloufi","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tig.2021.10.002","article-title":"Classical and noncanonical functions of miRNAs in cancers","volume":"38","author":"Dragomir","year":"2022","journal-title":"Trends Genet"},{"key":"10.1016\/j.prp.2023.154363_bib59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","article-title":"A review of the biological role of miRNAs in prostate cancer suppression and progression","volume":"197","author":"Doghish","year":"2022","journal-title":"Int J. Biol. Macromol."},{"issue":"7795","key":"10.1016\/j.prp.2023.154363_bib60","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","article-title":"Loss of p53 drives neuron reprogramming in head and neck cancer","volume":"578","author":"Amit","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.prp.2023.154363_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/ng2079","article-title":"Target mimicry provides a new mechanism for regulation of microRNA activity","volume":"39","author":"Franco-Zorrilla","year":"2007","journal-title":"Nat. Genet"},{"issue":"9","key":"10.1016\/j.prp.2023.154363_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.prp.2023.154363_bib63","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2014.10.029","article-title":"Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics","volume":"81","author":"Yang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.prp.2023.154363_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119904","article-title":"Agomelatine attenuates alcohol craving and withdrawal symptoms by modulating the Notch1 signaling pathway in rats","volume":"284","author":"Fathi","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154363_bib65","article-title":"Genetic impact of vitamin D receptor TaqI polymorphism on the risk of osteoporotic fractures in diabetic patients","volume":"27","author":"Abdelmaksoud","year":"2022","journal-title":"Gene Rep."},{"key":"10.1016\/j.prp.2023.154363_bib66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mgene.2016.11.005","article-title":"Clinical significance of TNFAIP3 rs2230926 T> G gene polymorphism in Egyptian cases with rheumatoid arthritis","volume":"11","author":"Elkhawaga","year":"2017","journal-title":"Meta Gene"},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib67","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/gutjnl-2019-318279","article-title":"Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility","volume":"69","author":"Dragomir","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.prp.2023.154363_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106104","article-title":"Role of dysregulated miRNAs profiles as hallmarks in the pathogenesis and differential regulation of tongue squamous cell carcinoma","volume":"134","author":"Yasasve","year":"2022","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.prp.2023.154363_bib69","article-title":"Transcriptional expression of miRNAs under glucose depletion\/2-deoxy-d-glucose in HCC: A possible genetic footprints of angiogenesis and its hallmarks","volume":"24","author":"Umapathy","year":"2021","journal-title":"Gene Rep."},{"key":"10.1016\/j.prp.2023.154363_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106475","article-title":"Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions","volume":"185","author":"Hashemi","year":"2022","journal-title":"Pharm. Res"},{"issue":"5","key":"10.1016\/j.prp.2023.154363_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2007.10.028","article-title":"p53 enters the microRNA world","volume":"12","author":"Hermeking","year":"2007","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.prp.2023.154363_bib72","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2023.154363_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120675","article-title":"Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-\u03baB pathways and LncRNA-AF085935\/GPC3 axis","author":"Al-Noshokaty","year":"2022","journal-title":"J. Life Sci."},{"issue":"2","key":"10.1016\/j.prp.2023.154363_bib74","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bj.2020.03.001","article-title":"The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness","volume":"43","author":"Wu","year":"2020","journal-title":"Biomed. J."},{"issue":"6","key":"10.1016\/j.prp.2023.154363_bib75","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/cells8060528","article-title":"Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells","volume":"8","author":"Ullmann","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.prp.2023.154363_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118518","article-title":"Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein","volume":"262","author":"El-Mahdy","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12943-016-0574-7","article-title":"Understanding of leukemic stem cells and their clinical implications","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2023.154363_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154053","article-title":"A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay","volume":"237","author":"Doghish","year":"2022","journal-title":"Pathol. Res. Pract."},{"issue":"6","key":"10.1016\/j.prp.2023.154363_bib79","first-page":"2956","article-title":"MiR-155 up-regulated by TGF-\u03b2 promotes epithelial-mesenchymal transition, invasion and metastasis of human hepatocellular carcinoma cells in vitro","volume":"9","author":"Li","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib80","first-page":"96","article-title":"MiR-133a and MiR-155 as potential minimally invasive biomarkers in breast cancer","volume":"7","author":"Elshimy","year":"2017","journal-title":"Cancer Biol."},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib81","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.sjbs.2021.02.001","article-title":"MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8","volume":"28","author":"Elkady","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib82","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.gendis.2021.10.009","article-title":"MicroRNAs and JAK\/STAT3 signaling: A new promising therapeutic axis in blood cancers","volume":"9","author":"Sajjadi-Dokht","year":"2022","journal-title":"Genes Dis."},{"issue":"11","key":"10.1016\/j.prp.2023.154363_bib83","first-page":"4944","article-title":"Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia blood","volume":"109","author":"Fulci","year":"2007","journal-title":"J. Am. Soc. Hematol."},{"issue":"12","key":"10.1016\/j.prp.2023.154363_bib84","first-page":"5079","article-title":"Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice, blood","volume":"109","author":"Raveche","year":"2007","journal-title":"J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0112-x","article-title":"Role of microRNA in chronic lymphocytic leukemia onset and progression","volume":"8","author":"Balatti","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2023.154363_bib86","first-page":"179","article-title":"Pathophysiology roles and translational opportunities of miRNAs in CLL, MicroRNA in Human Malignancies","author":"Veronese","year":"2022","journal-title":"Elsevier"},{"issue":"11","key":"10.1016\/j.prp.2023.154363_bib87","first-page":"2520","article-title":"miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines","volume":"127","author":"Zhu","year":"2010"},{"issue":"24","key":"10.1016\/j.prp.2023.154363_bib88","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1158\/0008-5472.CAN-06-3613","article-title":"Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181","volume":"66","author":"Pekarsky","year":"2006","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib89","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","article-title":"Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes","volume":"9","author":"Xiao","year":"2008","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib90","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3892\/mmr.2020.11111","article-title":"Upregulation of microRNA\u20111 inhibits proliferation and metastasis of breast cancer","volume":"22","author":"Peng","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2023.154363_bib91","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1746-1596-3-16","article-title":"Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence","volume":"3","author":"Frater","year":"2008","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2023.154363_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117628","article-title":"Androgen\/androgen receptor affects gentamicin-induced nephrotoxicity through regulation of megalin expression","volume":"251","author":"Elsakka","year":"2020","journal-title":"Life Sci."},{"issue":"23","key":"10.1016\/j.prp.2023.154363_bib93","doi-asserted-by":"crossref","first-page":"14865","DOI":"10.1039\/D2RA01968J","article-title":"Discovery of pyrazolo [3, 4-d] pyrimidine and pyrazolo [4, 3-e][1, 2, 4] triazolo [1, 5-c] pyrimidine derivatives as novel CDK2 inhibitors: synthesis, biological and molecular modeling investigations","volume":"12","author":"Nassar","year":"2022","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib94","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/14756366.2021.1901089","article-title":"Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"36","author":"Kassab","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"10","key":"10.1016\/j.prp.2023.154363_bib95","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/ph15101262","article-title":"Identification of novel cyanopyridones and pyrido [2, 3-D] pyrimidines as anticancer agents with dual VEGFR-2\/HER-2 inhibitory action: synthesis, biological evaluation and molecular docking studies","volume":"15","author":"Al-Warhi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2023.154363_bib96","doi-asserted-by":"crossref","unstructured":"A. Garc\u00eda-Pardo, J. Redondo-Mu\u00f1oz, Regulation and function of angiogenic factors in chronic lymphocytic leukemia, (2021).","DOI":"10.20517\/2394-4722.2021.103"},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib97","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14756366.2021.2015343","article-title":"New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies","volume":"37","author":"Elkady","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib98","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/14756366.2021.2015342","article-title":"1, 3, 4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies","volume":"37","author":"Hagras","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"46","key":"10.1016\/j.prp.2023.154363_bib99","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1039\/D1RA04345E","article-title":"Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer","volume":"11","author":"Doghish","year":"2021","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-018-0766-4","article-title":"New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2023.154363_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154211","article-title":"Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase","volume":"240","author":"Ismail","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154363_bib102","article-title":"Nanocomposite based on gold nanoparticles and carboxymethyl cellulose: synthesis, characterization, antimicrobial, and anticancer activities","volume":"77","author":"Doghish","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"16","key":"10.1016\/j.prp.2023.154363_bib103","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/polym14163352","article-title":"Synthesis of silver nanocomposite based on carboxymethyl cellulose: Antibacterial, antifungal and anticancer activities","volume":"14","author":"Salem","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.prp.2023.154363_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108656","article-title":"Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase","volume":"160","author":"Ismail","year":"2020","journal-title":"Steroids"},{"issue":"22","key":"10.1016\/j.prp.2023.154363_bib105","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2008-10-185686","article-title":"Aberrant regulation of pVHL levels by microRNA promotes the HIF\/VEGF axis in CLL B cells","volume":"113","author":"Ghosh","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib106","first-page":"778","article-title":"The regulation of tumor-suppressive microRNA, miR-126","volume":"6","author":"Guinn","year":"2017","journal-title":"Chronic Lymph. Leuk."},{"issue":"6","key":"10.1016\/j.prp.2023.154363_bib107","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/leu.2008.377","article-title":"miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities","volume":"23","author":"Mraz","year":"2009","journal-title":"Leukemia"},{"issue":"14","key":"10.1016\/j.prp.2023.154363_bib108","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1182\/blood-2010-05-285064","article-title":"MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia","volume":"117","author":"Vargova","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib109","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.1038\/s41598-017-12135-7","article-title":"Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia","volume":"7","author":"Carabia","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2023.154363_bib110","doi-asserted-by":"crossref","unstructured":"R. Visone, A. Veronese, L.Z. Rassenti, V. Balatti, D.K. Pearl, M. Acunzo, S. Volinia, C. Taccioli, T.J. Kipps, C.M. Croce, miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia, Blood 118(11) (2011) 3072\u20133079. DOI 10.1182\/blood-2011\u201301-333484%J Blood.","DOI":"10.1182\/blood-2011-01-333484"},{"issue":"2","key":"10.1016\/j.prp.2023.154363_bib111","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3892\/etm.2020.8771","article-title":"MicroRNA\u2011425 inhibits proliferation of chronic lymphocytic leukaemia cells through regulation of the Bruton's tyrosine kinase\/phospholipase C\u03b32 signalling pathway","volume":"20","author":"Chen","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.prp.2023.154363_bib112","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.1480","article-title":"Apoptosis inducers in chronic lymphocytic leukemia","volume":"5","author":"Billard","year":"2014","journal-title":"Oncotarget"},{"issue":"39","key":"10.1016\/j.prp.2023.154363_bib113","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2023.154363_bib114","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/JBM.S230842","article-title":"Serum expression of seven MicroRNAs in chronic lymphocytic leukemia patients","volume":"11","author":"Farzadfard","year":"2020","journal-title":"J. blood Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s43042-022-00345-2","article-title":"Decreased cell proliferation and induced apoptosis in human B-chronic lymphocytic leukemia following miR-221 inhibition through modulation of p27 expression","volume":"23","author":"Ashrafi Dehkordi","year":"2022","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib116","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.dsx.2018.11.058","article-title":"Plasma endoglin in Type2 diabetic patients with nephropathy","volume":"13","author":"Doghish","year":"2019","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"3","key":"10.1016\/j.prp.2023.154363_bib117","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/2211536602666131126002337","article-title":"MicroRNAs as main players in the pathogenesis of chronic lymphocytic leukemia","volume":"2","author":"Bottoni","year":"2013","journal-title":"MicroRNA"},{"key":"10.1016\/j.prp.2023.154363_bib118","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"21","key":"10.1016\/j.prp.2023.154363_bib119","doi-asserted-by":"crossref","DOI":"10.3760\/cma.j.issn.0366-6999.20130414","article-title":"Role of signaling pathways and miRNAs in chronic lymphocytic leukemia","volume":"126","author":"Li","year":"2013","journal-title":"Chin. Med J."},{"issue":"5","key":"10.1016\/j.prp.2023.154363_bib120","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.devcel.2018.01.020","article-title":"Activation of the notch signaling pathway in vivo elicits changes in CSL nuclear dynamics","volume":"44","author":"Gomez-Lamarca","year":"2018","journal-title":"Dev. Cell"},{"issue":"48","key":"10.1016\/j.prp.2023.154363_bib121","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0606108103","article-title":"NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth","volume":"103","author":"Palomero","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2023.154363_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2019.101436","article-title":"miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations","volume":"47","author":"Li","year":"2019","journal-title":"Mol. Cell Probes"},{"issue":"2","key":"10.1016\/j.prp.2023.154363_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2009.11.012","article-title":"Cross-talk between miRNA and Notch signaling pathways in tumor development and progression","volume":"292","author":"Wang","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2023.154363_bib124","article-title":"Carnosine and crocin ameliorate oxidative stress in rats with rhabdomyolysis-induced acute kidney injury through upregulating HO-1 gene expression, Food","volume":"49","author":"El-Ashmawy","year":"2022","journal-title":"Bioscience"},{"issue":"2","key":"10.1016\/j.prp.2023.154363_bib125","first-page":"953","article-title":"Protective effect of proanthocyanidins on nephrotoxicity induced by antitumor dose of cisplatin in ehrlich solid tumor-bearing mice","volume":"40","author":"Salman","year":"2014","journal-title":"Arab. J. Lab. Med."},{"key":"10.1016\/j.prp.2023.154363_bib126","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/967585","article-title":"Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia","volume":"2014","author":"Duyu","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"10.1016\/j.prp.2023.154363_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.27746","article-title":"Frizzled homolog proteins, microRNAs and Wnt signaling in cancer","volume":"132","author":"Ueno","year":"2013","journal-title":"Int J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib128","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbrc.2018.06.045","article-title":"Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607\/FZD3\/Wnt\/beta-catenin pathway","volume":"503","author":"Xia","year":"2018","journal-title":"Biochem. Biophys. Res Commun."},{"key":"10.1016\/j.prp.2023.154363_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.712546","article-title":"Non-coding RNA and frizzled receptors in cancer","volume":"8","author":"Smith","year":"2021","journal-title":"Front Mol. Biosci."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5214\/ans.0972.7531.210109","article-title":"Sonic hedgehog signalling pathway: a complex network","volume":"21","author":"Choudhry","year":"2014","journal-title":"Ann. Neurosci."},{"issue":"11","key":"10.1016\/j.prp.2023.154363_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/cells7110208","article-title":"Hedgehog signaling in cancer: a prospective therapeutic target for eradicating cancer stem cells","volume":"7","author":"Sari","year":"2018","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib132","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ajpath.2011.09.009","article-title":"Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms","volume":"180","author":"Ok","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2023.154363_bib133","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.2147\/CMAR.S214405","article-title":"The Hedgehog signal transducer Smoothened and microRNA-326: pathogenesis and regulation of drug resistance in pediatric B-cell acute lymphoblastic leukemia","volume":"11","author":"Sheybani","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib134","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1756-9966-33-54","article-title":"miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1","volume":"33","author":"Ma","year":"2014","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.prp.2023.154363_bib135","article-title":"The emerging role of noncoding RNAs in the Hedgehog signaling pathway in cancer","volume":"154","author":"Han","year":"2022","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.prp.2023.154363_bib136","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011205","article-title":"The Jak\/STAT pathway","volume":"4","author":"Harrison","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"21","key":"10.1016\/j.prp.2023.154363_bib137","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.prp.2023.154363_bib138","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.neo.2021.10.003","article-title":"STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications","volume":"23","author":"Tosic","year":"2021","journal-title":"Neoplasia"},{"issue":"10","key":"10.1016\/j.prp.2023.154363_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/genes10100752","article-title":"MicroRNA in pancreatic cancer: from biology to therapeutic potential","volume":"10","author":"Rawat","year":"2019","journal-title":"Genes"},{"issue":"11","key":"10.1016\/j.prp.2023.154363_bib140","doi-asserted-by":"crossref","DOI":"10.1590\/S0100-879X2007001100003","article-title":"miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia","volume":"40","author":"Zanette","year":"2007","journal-title":"Braz. J. Med Biol. Res"},{"key":"10.1016\/j.prp.2023.154363_bib141","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.2147\/CMAR.S174476","article-title":"Abnormal microRNA expression in the course of hematological malignancies","volume":"10","author":"Szymczyk","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib142","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.1038\/s41598-017-12135-7","article-title":"Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia","volume":"7","author":"Carabia","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.prp.2023.154363_bib143","first-page":"3064","article-title":"Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia","volume":"39","author":"Chen","year":"2018","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.prp.2023.154363_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/nu13072245","article-title":"The role of miR-155 in nutrition: modulating cancer-associated inflammation","volume":"13","author":"Zanoaga","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.prp.2023.154363_bib145","doi-asserted-by":"crossref","first-page":"8060182","DOI":"10.1155\/2016\/8060182","article-title":"miR-155 regulated inflammation response by the SOCS1-STAT3-PDCD4 axis in Atherogenesis","volume":"2016","author":"Ye","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"9","key":"10.1016\/j.prp.2023.154363_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007169","article-title":"Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL","volume":"4","author":"Hanlon","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib147","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/leu.2014.139","article-title":"Allele-specific loss and transcription of the miR-15a\/16-1 cluster in chronic lymphocytic leukemia","volume":"29","author":"Veronese","year":"2015","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.prp.2023.154363_bib148","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41375-018-0303-x","article-title":"The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia","volume":"33","author":"ten Hacken","year":"2019","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2007.07.021","article-title":"MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb","volume":"131","author":"Xiao","year":"2007","journal-title":"Cell"},{"issue":"33","key":"10.1016\/j.prp.2023.154363_bib150","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1220710110","article-title":"MicroRNA-126-mediated control of cell fate in B-cell myeloid progenitors as a potential alternative to transcriptional factors","volume":"110","author":"Okuyama","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5654","key":"10.1016\/j.prp.2023.154363_bib151","doi-asserted-by":"crossref","DOI":"10.1126\/science.1091903","article-title":"MicroRNAs modulate hematopoietic lineage differentiation","volume":"303","author":"Chen","year":"2004","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib152","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1189\/jlb.1HI0915-398RR","article-title":"The mirn23a microRNA cluster antagonizes B cell development","volume":"100","author":"Kurkewich","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"8","key":"10.1016\/j.prp.2023.154363_bib153","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ni.2641","article-title":"Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells","volume":"14","author":"Nechanitzky","year":"2013","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib154","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/eji.201847660","article-title":"miR-191 modulates B-cell development and targets transcription factors E2A, Foxp1, and Egr1","volume":"49","author":"Blume","year":"2019","journal-title":"Eur. J. Immunol."},{"issue":"13","key":"10.1016\/j.prp.2023.154363_bib155","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.18632\/oncotarget.3433","article-title":"MicroRNA-146a modulates B-cell oncogenesis by regulating Egr1","volume":"6","author":"Contreras","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib156","first-page":"546","article-title":"MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia blood","volume":"124","author":"Cui","year":"2014","journal-title":"J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib157","first-page":"84","article-title":"miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1, Blood","volume":"124","author":"Mraz","year":"2014","journal-title":"J. Am. Soc. Hematol."},{"issue":"2","key":"10.1016\/j.prp.2023.154363_bib158","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41375-018-0230-x","article-title":"MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells","volume":"33","author":"Cerna","year":"2019","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.prp.2023.154363_bib159","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood.2020005627","article-title":"miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors","volume":"137","author":"Sharma","year":"2021","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.prp.2023.154363_bib160","first-page":"2310","article-title":"Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL, blood","volume":"127","author":"Shukla","year":"2016","journal-title":"J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib161","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","article-title":"TLR signaling","volume":"19","author":"Kawai","year":"2007","journal-title":"Semin Immunol."},{"issue":"5","key":"10.1016\/j.prp.2023.154363_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"issue":"7007","key":"10.1016\/j.prp.2023.154363_bib163","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/431405a","article-title":"An inflammatory link","volume":"431","author":"Balkwill","year":"2004","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.prp.2023.154363_bib164","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/leu.2012.44","article-title":"The miR-17\u223c 92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes","volume":"26","author":"Bomben","year":"2012","journal-title":"Leukemia"},{"issue":"31","key":"10.1016\/j.prp.2023.154363_bib165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"28","key":"10.1016\/j.prp.2023.154363_bib166","doi-asserted-by":"crossref","first-page":"11499","DOI":"10.1073\/pnas.1219852110","article-title":"Negative regulation of Toll-like receptor 4 signaling by IL-10\u2013dependent microRNA-146b","volume":"110","author":"Curtale","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.prp.2023.154363_bib167","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.4049\/jimmunol.1502297","article-title":"B cell anergy modulated by TLR1\/2 and the miR-17\u223c 92 cluster underlies the indolent clinical course of chronic lymphocytic leukemia stereotyped subset# 4","volume":"196","author":"Ntoufa","year":"2016","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib168","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3324\/haematol.2009.010272","article-title":"Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition","volume":"95","author":"Zhuang","year":"2010","journal-title":"haematologica"},{"issue":"21","key":"10.1016\/j.prp.2023.154363_bib169","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1007\/s00018-012-1129-8","article-title":"The AKT-associated microRNAs","volume":"69","author":"Xu","year":"2012","journal-title":"Cell. Mol. life Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3324\/haematol.2017.165381","article-title":"Microenvironmental stromal cells abrogate NF-\u03baB inhibitor-induced apoptosis in chronic lymphocytic leukemia","volume":"103","author":"Carl Philipp","year":"2018","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.prp.2023.154363_bib171","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/ijc.29491","article-title":"Epigenetic silencing of miR\u2010708 enhances NF\u2010\u03baB signaling in chronic lymphocytic leukemia","volume":"137","author":"Baer","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"18","key":"10.1016\/j.prp.2023.154363_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186720","article-title":"Non-coding RNAs as cancer hallmarks in chronic lymphocytic leukemia","volume":"21","author":"Fabris","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.prp.2023.154363_bib173","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/leu.2015.119","article-title":"p53-dependent non-coding RNA networks in chronic lymphocytic leukemia","volume":"29","author":"Blume","year":"2015","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.prp.2023.154363_bib174","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/10408363.2018.1499707","article-title":"Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome","volume":"55","author":"Jurj","year":"2018","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/gcc.22236","article-title":"Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR\u2010132 and miR\u2010212","volume":"54","author":"Tavolaro","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-9-123","article-title":"MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia","volume":"9","author":"Ferracin","year":"2010","journal-title":"Mol. Cancer"},{"issue":"28","key":"10.1016\/j.prp.2023.154363_bib177","first-page":"11499","volume":"110","author":"Curtale","year":"2013","journal-title":"Negative regulation of Toll-like receptor 4 signaling by IL-10\u2013dependent microRNA-146b"},{"issue":"22","key":"10.1016\/j.prp.2023.154363_bib178","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1182\/blood.V128.22.968.968","article-title":"Comparative evaluation of prognostic factors that assess the natural history of chronic lymphocytic leukemia","volume":"128","author":"Giacopelli","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.prp.2023.154363_bib179","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/jcp.25799","article-title":"State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia","volume":"233","author":"Mirzaei","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.prp.2023.154363_bib180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/cgt.2016.34","article-title":"Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia","volume":"23","author":"Fathullahzadeh","year":"2016","journal-title":"Cancer Gene Ther."},{"issue":"3","key":"10.1016\/j.prp.2023.154363_bib181","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016956","article-title":"MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells","volume":"6","author":"Li","year":"2011","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib182","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-015-0224-3","article-title":"ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development","volume":"8","author":"Cang","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2023.154363_bib183","article-title":"MiRNA-16-1 suppresses Mcl-1 and Bcl-2 and sensitizes chronic lymphocytic leukemia cells to BH3 Mimetic ABT-199","volume":"24","author":"Ashofteh","year":"2022","journal-title":"Cell J."},{"issue":"7","key":"10.1016\/j.prp.2023.154363_bib184","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/carcin\/bgs179","article-title":"miR-181a\/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes","volume":"33","author":"Zhu","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.prp.2023.154363_bib185","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.2147\/CMAR.S191311","article-title":"Assessment of microRNA expression in leukemic cells as predictors of sensitivity to purine nucleoside analogs, fludarabine and cladribine, in chronic lymphocytic leukemia patients","volume":"11","author":"Szymczyk","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib186","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/leu.2013.125","article-title":"Loss of p53 and altered miR15-a\/16-1\u2192MCL-1 pathway in CLL: insights from TCL1-Tg:p53\u2212\/\u2212 mouse model and primary human leukemia cells","volume":"28","author":"Liu","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.prp.2023.154363_bib187","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1158\/1535-7163.MCT-09-0127","article-title":"Correcting miR-15a\/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity","volume":"8","author":"Salerno","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.prp.2023.154363_bib188","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1476-4598-9-123","article-title":"MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia","volume":"9","author":"Ferracin","year":"2010","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2023.154363_bib189","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/1078-0432.CCR-12-1922","article-title":"In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of toll-like receptors","volume":"19","author":"Fonte","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.prp.2023.154363_bib190","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41419-021-04353-9","article-title":"Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies","volume":"12","author":"Kapoor","year":"2021","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.prp.2023.154363_bib191","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1002\/jcb.29541","article-title":"Downregulation of microRNA let-7f mediated the Adriamycin resistance in leukemia cell line","volume":"121","author":"Cao","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.prp.2023.154363_bib192","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3324\/haematol.2016.153189","article-title":"miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study","volume":"102","author":"Anne-Laure","year":"2017","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.prp.2023.154363_bib193","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/leu.2012.106","article-title":"Impact of serum storage conditions on microRNA stability","volume":"26","author":"Grasedieck","year":"2012","journal-title":"Leukemia"},{"issue":"3-4","key":"10.1016\/j.prp.2023.154363_bib194","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.proghi.2016.06.001","article-title":"Intracellular and extracellular microRNA: an update on localization and biological role","volume":"51","author":"Makarova","year":"2016","journal-title":"Prog. Histochem. Cytochem."},{"issue":"5","key":"10.1016\/j.prp.2023.154363_bib195","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s40291-019-00410-4","article-title":"MicroRNAs: key players in bladder cancer","volume":"23","author":"Li","year":"2019","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.prp.2023.154363_bib196","doi-asserted-by":"crossref","unstructured":"G.A. Calin, C.M. Croce, Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance, Elsevier, pp. 167\u2013173.","DOI":"10.1053\/j.seminoncol.2006.01.010"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:56:17Z","timestamp":1759733777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":196,"alternative-id":["S0344033823000638"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154363","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance\u2013 An emphasis on the interaction of signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154363"}}